Home › Kanser sa Pantog › Ohio › Cleveland

Pag-aaral pangklinika para sa Kanser sa Pantog sa Cleveland, OH

Isang pag-aaral para sa Kanser sa Pantog ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Cleveland. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Nagre-recruitPhase 1

University Hospitals Cleveland Medical Center, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06465069

KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)

Nagre-recruitPhase 1/2

Cleveland Clinic Taussig Cancer ( Site 5036), Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07232602

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Nagre-recruitPhase 2

Cleveland Clinic - Oncology Department, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06760819

Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy

Nagre-recruitPhase 2

Cleveland Clinic Taussig Cancer Center, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06263153

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Nagre-recruitPhase 2

MetroHealth Medical Center, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07061964

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Nagre-recruitPhase 1/2

University Hospitals Cleveland Medical Center, Cleveland
Cleveland Clinic Foundation, Cleveland
Cleveland Clinic Taussig Cancer Center Investigational Pharmacy, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07421700

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

Nagre-recruitPhase 1

University Hospitals Cleveland Medical Center, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07217171

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Nagre-recruitObservasyonal na pag-aaral

Cleveland Clinic, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT05059444

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Nagre-recruitPhase 2

Cleveland Clinic, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06567743

The Vanguard Study: Testing a New Way to Screen for Cancer

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Louis Stokes Cleveland VA Medical Center, Cleveland

Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06995898

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Nagre-recruitPhase 2

Cleveland Clinic Main Campus, Cleveland, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05951179

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Nagre-recruitPhase 3

Case Western Reserve University, Cleveland
UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi ang layo
UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 22 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07097142

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

Nagre-recruitPhase 2/3

Fairview Hospital, Cleveland
Cleveland Clinic, Cleveland
Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · 12 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT07106762

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

Nagre-recruitPhase 3

Research Site, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT07720284

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Nagre-recruitPhase 2

University Hospitals Cleveland Medical Center, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT04879329

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1/2

Cleveland Clinic, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 18, 2026 · NCT07030257

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Cleveland Clinic, Cleveland

Edad 40 pataas · Lahat ng kasarian · Na-update Ene 20, 2026 · NCT05366881

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi ang layo

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Kanser sa Pantog sa ibang lungsod

Iba pang pag-aaral sa Cleveland

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.